NVE (NVEC) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 FY2025 declined 23% year-over-year to $6.78 million, mainly due to a 24% drop in product sales, partially offset by a 28% increase in contract R&D revenue.

• Net income decreased 7% year-over-year to $4.10 million, or $0.85 per diluted share, with higher gross margin and interest income partially offsetting lower revenue.

• Gross margin improved to 86% from 77% year-over-year, driven by a more profitable product mix and higher direct sales.

• Operating cash flow increased 16% to $5.9 million, supporting a $4.83 million dividend.

• Comprehensive income was down just 1% due to unrealized gains on marketable securities.

Financial highlights

• Product sales were $6.62 million, down from $8.70 million year-over-year; contract R&D revenue rose to $167,000 from $131,000.

• Total revenue: $6.8 million for Q1 FY2025, down from $8.8 million in Q1 FY2024.

• Cash and cash equivalents stood at $6.01 million as of June 30, 2024, down from $10.28 million at March 31, 2024.

• Cash plus marketable securities rose to $53.2 million, even after dividend and $917,000 in CapEx.

• Cash dividends paid: $1.00 per share, totaling $4.8 million in the quarter.

Outlook and guidance

• Industry forecasts indicate recovery in calendar 2024 and strong growth in 2025.

• Investments in wafer-level chip-scale packaging and increased fixed asset purchases expected to drive future revenue and margin improvement.

• Defense business, including PUFs, expected to remain strong in the near term.

• Future dividends will be funded by operating cash flow and maturing securities, subject to Board approval and business conditions.

• Management expressed satisfaction with earnings performance despite industry challenges.